Page last updated: 2024-08-23

captopril and chf 1024

captopril has been researched along with chf 1024 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Annoni, G; Arosio, B; Bernasconi, R; Bongrani, S; Calvillo, L; Chimenti, S; Gagliano, N; Latini, R; Limana, F; Masson, S; Razzetti, R; Salio, M; Santambrogio, D; Torri, M	1

Other Studies

1 other study(ies) available for captopril and chf 1024

Article	Year
CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload. Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:2 Topics: Adrenergic alpha-Agonists; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Captopril; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Renal; Ligation; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes	2001

Article

Year

CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload.

Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:2

Topics: Adrenergic alpha-Agonists; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Captopril; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Renal; Ligation; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes

2001